TITLE

THE MAIL

AUTHOR(S)
van der Weide, Daniel; Jongerius, Kim; Newman, Sarah; Dunn, Alan
PUB. DATE
November 2017
SOURCE
New Yorker;11/27/2017, Vol. 93 Issue 38, p3
SOURCE TYPE
Periodical
DOC. TYPE
Letter to the Editor
ABSTRACT
No abstract available.
ACCESSION #
126284049

 

Related Articles

  • Dr. Robert Goldman About Anti-Aging. Furney, William J. // Spa Management;Mar2010, Vol. 20 Issue 3, p24 

    The article presents an interview with Robert Goldman, a pioneer in the field of anti-aging, about the growth of the field. Goldman discusses anti-aging as a medical specialty founded on the treatment and prevention of age-related diseases. He explains the involvement of exercise and diet in...

  • News Briefs.  // MondayMorning;5/19/2014, Vol. 22 Issue 19, p7 

    This section offers news briefs on the U.S. health care industry as of May 2014. Research studies discussed focused on the benefits of exercising for men over 70 years with high blood pressure, the risk of breast cancer for obese women younger than 50, and the influence of physical inactivity in...

  • Knowledge and Practice Assessment of Workers in a Pharmaceutical Company about Prevention of Coronary Artery Disease. Attarchi, Mirsaeed; Mohammadi, Saber; Nojomi, Marzieh; Labbafinejad, Yasser // Acta Medica Iranica;2012, Vol. 50 Issue 10, p697 

    Coronary artery disease is one of the most common reasons of death around the world. Also, according to previous studies, the incidence of coronary artery disease is rapidly increasing in developing countries such as Iran. The aim of this study was to evaluate the knowledge and practice of...

  • Our Drugs Addiction. Loftus, Matthew // Christianity Today;May2016, Vol. 60 Issue 4, p26 

    The article offers the author's insights on the drugs addiction in the U.S. Topics discussed by the author include the concern of the manufacturers regarding the cost of developing a drug, higher expense of the pharmaceutical companies on marketing and advertising, and problem of drug prices....

  • From Europe to China--a new focus. Wechsler, Jill // Pharmaceutical Executive;Sep97, Vol. 17 Issue 9, p20 

    Focuses on the pharmaceutical industry in the People's Republic of China. Signing of the Mutual Recognition Agreement on pharmaceutical plant inspection between the United States and Europe; Upgrading of domestic pharmaceutical capabilities in the country; Difficulty of drug distribution in the...

  • Ethics & enterprise--industry's dilemma. Schwartz, Harry // Pharmaceutical Executive;Nov97, Vol. 17 Issue 11, p24 

    Discusses the problems faced by the pharmaceutical industry in the United States involving ethical issues and standard practices. Collapse in the diet-drug demand due to its alleged adverse reaction; Lawsuit faced by SmithKline Beecham; Pediatric drugs not properly labeled and tested; Stiff...

  • Nigeria--strategy & strength for industry. Akanmu, Olu // Pharmaceutical Executive;Nov97, Vol. 17 Issue 11, p74 

    Focuses on the status and the restructuring trend of the pharmaceutical industry in Nigeria. Glaxo Wellcome's restructured business; Economic conditions of Nigeria; Government policies toward business; Presence of diverse pharmaceutical companies; Sale of over-the-counter drugs; Logistics and...

  • Information showcase.  // Pharmaceutical Executive;Nov97, Vol. 17 Issue 11, p85 

    Showcases products and services related to the pharmaceutical industry in the United States. Includes marketing support services; Book entitled `Contemporary Pharmacoeconomics'; Medical handbooks; Reporting services; Production services; Biotechnology support.

  • Homeopathic drugs naturally want spot in mainstream market. Magiera, Marcy; Colford, Steven W. // Advertising Age;8/31/92, Vol. 63 Issue 35, p3 

    Reports that marketers of homeopathic medicines want to write a prescription for the American mainstream and they are spending marketing dollars doing it. Remedies that treat an ailment with small doses of natural substances; Commonly available in Europe; Homeopathic marketers expect that to...

  • New drugs often not that new.  // Aging;1991, Issue 362, p44 

    Reports on a study by the Senate Special Committee on Aging that found the vast majority of new pharmaceuticals placed on the market have little or no advantage over the usually less expensive drug therapies.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics